Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Recruiting
Observational Study
Gastric Cancer
Atrophic Gastritis
Gastric Dysplasia
H.Pylori Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- University of Latvia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with verified gastric cancer (Group 1 \& 2)
* Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5)
* Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
* Motivation to participate …
Contacts